GlassScriptPhysician profile
Eamonn Byrnes
NPI 1174253066
$6,464.21
in general payments reported to CMS, 2019-2025
8 companies · $6,194 in 2025
The $6,194 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $62.48 · 2024: $208 · 2025: $6,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,243 · Travel and Lodging: $2,945 · Education: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,242.67 |
| Travel and Lodging | $2,945.49 |
| Education | $276.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,379.83 | 2025 | Gallant, Merlin@Home, Ensite |
| Penumbra, INC. | $1,742.89 | 2025 | Indigo System, Penumbra System |
| Atricure, INC. | $726.42 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Abiomed | $317.32 | 2024-2025 | Impella |
| Janssen Pharmaceuticals, INC | $134.21 | 2024 | Xarelto |
| Edwards Lifesciences Corporation | $84.02 | 2025 | |
| Grifols USA, LLC | $62.48 | 2023 | Gamunex-C |
| Biotronik INC. | $17.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eamonn Byrnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.